Skip to main content
Top
Published in: BMC Public Health 1/2019

Open Access 01-12-2019 | Public Health | Research article

Establishing a theoretical foundation for measuring global health security: a scoping review

Authors: Sanjana J. Ravi, Diane Meyer, Elizabeth Cameron, Michelle Nalabandian, Beenish Pervaiz, Jennifer B. Nuzzo

Published in: BMC Public Health | Issue 1/2019

Login to get access

Abstract

Background

Since the 2014–2016 West Africa Ebola epidemic, the concept of measuring health security capacity has become increasingly important within the broader context of health systems-strengthening, enhancing responses to public health emergencies, and reducing global catastrophic biological risks. Efforts to regularly and sustainably track the evolution of health security capabilities and capacities over time – while also accounting for political, social, and environmental risks – could help countries progress toward eliminating sources of health insecurity. We sought to aggregate evidence-based principles that capture a country’s baseline public health and healthcare capabilities, its health security system performance before and during infectious disease crises, and its broader social, political, security, and ecological risk environments.

Methods

We conducted a scoping review of English-language scholarly and gray literature to identify evidence- and practice-based indicators and proxies for measuring health security at the country level over time. We then used a qualitative coding framework to identify recurrent themes in the literature and synthesize foundational principles for measuring global health security. Documents reviewed included English-language literature published after 2001 until the end of the research period—September 2017—to ensure relevance to the current global health security landscape; literature examining acute infectious disease threats with potential for transnational spread; and literature addressing global health security efforts at the country level.

Results

We synthesized four foundational principles for measuring global health security: measurement requires assessment of existing capacities, as well as efforts to build core public health, healthcare, and biosecurity capabilities; assessments of national programs and efforts to mitigate a critical subset of priority threats could inform efforts to generate useful metrics for global health security; there are measurable enabling factors facilitating health security-strengthening efforts; and finally, measurement requires consideration of social, political, and ecological risk environments.

Conclusion

The themes identified in this review could inform efforts to systematically assess the impacts and effectiveness of activities undertaken to strengthen global health security.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organization. Report of the Ebola interim assessment panel. Geneva, Switzerland: World Health Organization; 2015. World Health Organization. Report of the Ebola interim assessment panel. Geneva, Switzerland: World Health Organization; 2015.
3.
go back to reference Harvard Global Health Institute, National Academy of Medicine. Monitoring Global Health Security and Pandemic Preparedness. Boston, Massachusetts. 2017. Harvard Global Health Institute, National Academy of Medicine. Monitoring Global Health Security and Pandemic Preparedness. Boston, Massachusetts. 2017.
4.
go back to reference The National Academies of Sciences, Engineering, and Medicine. The Neglected Dimension of Global Security: A Framework to Counter Infectious Disease Crises. Washington, DC. 2016. The National Academies of Sciences, Engineering, and Medicine. The Neglected Dimension of Global Security: A Framework to Counter Infectious Disease Crises. Washington, DC. 2016.
7.
go back to reference Hamblion E, Salter M, Jones J. Achieving compliance with the international health regulations by overseas territories of the United Kingdom of Great Britain and Northern Ireland. Bull World Health Organ. 2014;92:836–43.PubMedPubMedCentralCrossRef Hamblion E, Salter M, Jones J. Achieving compliance with the international health regulations by overseas territories of the United Kingdom of Great Britain and Northern Ireland. Bull World Health Organ. 2014;92:836–43.PubMedPubMedCentralCrossRef
9.
go back to reference Aledort JE, Lurie N, Wasserman J, Bozzette SA. Non-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence base. BMC Public Health. 2007;7(208). Aledort JE, Lurie N, Wasserman J, Bozzette SA. Non-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence base. BMC Public Health. 2007;7(208).
10.
go back to reference Taboy C, Chapman W, Albetkova A, Kennedy S, Rayfield M. Integrated disease investigations and surveillance planning: a systems approach to strengthening national surveillance and detection of events of public health importance in support of the international health regulations. BMC Public Health. 2010;10(1):1–6.CrossRef Taboy C, Chapman W, Albetkova A, Kennedy S, Rayfield M. Integrated disease investigations and surveillance planning: a systems approach to strengthening national surveillance and detection of events of public health importance in support of the international health regulations. BMC Public Health. 2010;10(1):1–6.CrossRef
11.
go back to reference Courtney B, Toner E, Waldhorn R, Franco C, Rambhia K, Norwood A, et al. Healthcare coalitions: the new foundation for national healthcare preparedness and response for catastrophic health emergencies. Biosecur Bioterror. 2009;7(2):153–63.PubMedCrossRef Courtney B, Toner E, Waldhorn R, Franco C, Rambhia K, Norwood A, et al. Healthcare coalitions: the new foundation for national healthcare preparedness and response for catastrophic health emergencies. Biosecur Bioterror. 2009;7(2):153–63.PubMedCrossRef
12.
go back to reference Boisvert R, Kay D, Turvey C. Macroeconomic costs to large scale disruptions of food production: the case of foot- and-mouth disease in the United States. Econ Model. 2012;29:1921–30.CrossRef Boisvert R, Kay D, Turvey C. Macroeconomic costs to large scale disruptions of food production: the case of foot- and-mouth disease in the United States. Econ Model. 2012;29:1921–30.CrossRef
13.
go back to reference Bork K, Halkjae-Knudsen V, Hansen J, Heegard E. Biosecurity in Scandinavia. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 2007;5(1):62–72.CrossRef Bork K, Halkjae-Knudsen V, Hansen J, Heegard E. Biosecurity in Scandinavia. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 2007;5(1):62–72.CrossRef
15.
go back to reference Linacre N, Koo B, Rosegrant M, Msangi S, Falck-Zepeda GJ, et al. Security analysis for Agroterrorism: applying the threat, vulnerability, consequence framework to developing countries. Washington, DC: International Food Policy Research Institute; 2005. Linacre N, Koo B, Rosegrant M, Msangi S, Falck-Zepeda GJ, et al. Security analysis for Agroterrorism: applying the threat, vulnerability, consequence framework to developing countries. Washington, DC: International Food Policy Research Institute; 2005.
16.
go back to reference Anema A, Druyts E, Hollmeyer H, Hardiman M, KWilson K. Descriptive review and evaluation of the functioning of the international health regulations (IHR) annex 2. Glob Health. 2012;8(1).PubMedPubMedCentralCrossRef Anema A, Druyts E, Hollmeyer H, Hardiman M, KWilson K. Descriptive review and evaluation of the functioning of the international health regulations (IHR) annex 2. Glob Health. 2012;8(1).PubMedPubMedCentralCrossRef
17.
go back to reference MacIntyre C. Biopreparedness in the age of genetially engineered pathogens and open access science: an urgent need for a paradigm shift. Mil Med. 2015;180:943–9.PubMedCrossRef MacIntyre C. Biopreparedness in the age of genetially engineered pathogens and open access science: an urgent need for a paradigm shift. Mil Med. 2015;180:943–9.PubMedCrossRef
19.
go back to reference Gottron F, Shea D. Oversight of high-containment biological laboratories: issues for congress. Washington, DC; 2009. Gottron F, Shea D. Oversight of high-containment biological laboratories: issues for congress. Washington, DC; 2009.
20.
go back to reference World Health Organization. Responsible life sciences research for Global Health security: a guidance document. Geneva, Switzerland; 2010. World Health Organization. Responsible life sciences research for Global Health security: a guidance document. Geneva, Switzerland; 2010.
21.
go back to reference Abd El Ghany M, Hazem S, Hill-Cawthorne G. Hajj vaccinations - facts, challenges, and hope. Int J Infect Dis. 2016;47:29–37.PubMedCrossRef Abd El Ghany M, Hazem S, Hill-Cawthorne G. Hajj vaccinations - facts, challenges, and hope. Int J Infect Dis. 2016;47:29–37.PubMedCrossRef
22.
go back to reference Aledort J, Lurie N, Wasserman J, Bozzette S. Non-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence base. BMC Public Health. 2007;7. Aledort J, Lurie N, Wasserman J, Bozzette S. Non-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence base. BMC Public Health. 2007;7.
23.
go back to reference Jacobs L. Rights and quarantine during the SARS global health crisis: differentiated legal consciousness in Hong Kong, Shanghai, and Toronto. Law & Society Review. 2007;41(3):511–52.CrossRef Jacobs L. Rights and quarantine during the SARS global health crisis: differentiated legal consciousness in Hong Kong, Shanghai, and Toronto. Law & Society Review. 2007;41(3):511–52.CrossRef
24.
go back to reference Levi J, Inglesby T, Segal L, Vinter S. Pandemic flu preparedness: lessons from the frontlines. Washington, DC: Trust for America's Health; 2009. Levi J, Inglesby T, Segal L, Vinter S. Pandemic flu preparedness: lessons from the frontlines. Washington, DC: Trust for America's Health; 2009.
25.
go back to reference Hennessey M, Lee B, Goldsmith T, Halvorson D, Hueston W, McElroy K, et al. Supporting business continuity during a highly pathogenic avian influenza outbreak: a collaboration of industry, academia, and government. Avian Dis. 2010;54:387–9.PubMedCrossRef Hennessey M, Lee B, Goldsmith T, Halvorson D, Hueston W, McElroy K, et al. Supporting business continuity during a highly pathogenic avian influenza outbreak: a collaboration of industry, academia, and government. Avian Dis. 2010;54:387–9.PubMedCrossRef
26.
go back to reference Lev O, Samimian-Darash L. Biosecurity policy in the US: a critical assessment. Front Public Health. 2014;2(110):1–3. Lev O, Samimian-Darash L. Biosecurity policy in the US: a critical assessment. Front Public Health. 2014;2(110):1–3.
27.
go back to reference Link H. Playing god and the intrinsic value of life: moral problems for synthetic biology. Sci Eng Ethics. 2013;19:435–48.PubMedCrossRef Link H. Playing god and the intrinsic value of life: moral problems for synthetic biology. Sci Eng Ethics. 2013;19:435–48.PubMedCrossRef
29.
30.
go back to reference Fasina F, Joannis T, Abolnik C, McCrindle C, Bisschop S. Community measures: a key to highly pathogenic avian influenza control in developing nations. Intern J Appl Res Vet Med. 2006;4(3):249–54. Fasina F, Joannis T, Abolnik C, McCrindle C, Bisschop S. Community measures: a key to highly pathogenic avian influenza control in developing nations. Intern J Appl Res Vet Med. 2006;4(3):249–54.
31.
go back to reference Agunos A, Pierson FW, Lungu B, Dunn PA, Tablante N. Review of nonfoodborne zoonotic and potentially zoonotic poultry diseases. Avian Dis. 2016;60:553–75.PubMedCrossRef Agunos A, Pierson FW, Lungu B, Dunn PA, Tablante N. Review of nonfoodborne zoonotic and potentially zoonotic poultry diseases. Avian Dis. 2016;60:553–75.PubMedCrossRef
32.
go back to reference Artois M, Bicout D, Gavier-Widen D, et al. Outbreaks of highly pathogenic avian influenza in Europe: the risks associated with wild birds. Rev Sci Tech. 2009;28(1):69=92.PubMedCrossRef Artois M, Bicout D, Gavier-Widen D, et al. Outbreaks of highly pathogenic avian influenza in Europe: the risks associated with wild birds. Rev Sci Tech. 2009;28(1):69=92.PubMedCrossRef
33.
go back to reference Heymann D, Dixon M. Infections at the animal/human interface: shifting the paradigm from emergency response to prevention at source. Curr Top Microbiol Immunol. 2013;366:207–15.PubMed Heymann D, Dixon M. Infections at the animal/human interface: shifting the paradigm from emergency response to prevention at source. Curr Top Microbiol Immunol. 2013;366:207–15.PubMed
34.
go back to reference Dar O, Hasan R, Schlundt J, et al. Antimicrobials: access and sustainable eff ectiveness: exploring the evidence base for national and regional policy interventions to combat resistance. Lancet. 2016;387:285–95.PubMedCrossRef Dar O, Hasan R, Schlundt J, et al. Antimicrobials: access and sustainable eff ectiveness: exploring the evidence base for national and regional policy interventions to combat resistance. Lancet. 2016;387:285–95.PubMedCrossRef
35.
go back to reference Ahmed A, Barbeschi M, Memish Z. The quest for public health security at hajj: the WHO guidelines on communicable disease alert and response during mass gatherings. Travel Med Infect Dis. 2009;7:226–30.PubMedCrossRef Ahmed A, Barbeschi M, Memish Z. The quest for public health security at hajj: the WHO guidelines on communicable disease alert and response during mass gatherings. Travel Med Infect Dis. 2009;7:226–30.PubMedCrossRef
36.
go back to reference Huang Y. Managing biosecurity threats in China. Biosecurity and Bioterrorism: Biodefense Strategy. Practice, and Science. 2007;9(1):31–40. Huang Y. Managing biosecurity threats in China. Biosecurity and Bioterrorism: Biodefense Strategy. Practice, and Science. 2007;9(1):31–40.
37.
go back to reference World Health Organization. Responsible life sciences research for global health security: a guidance document. Geneva, Switzerland: World Health Organization; 2010. World Health Organization. Responsible life sciences research for global health security: a guidance document. Geneva, Switzerland: World Health Organization; 2010.
38.
go back to reference National Research Council of the National Academies. In: Academies TN, editor. Sequence-based classification of select agents. Washington, DC; 2010. National Research Council of the National Academies. In: Academies TN, editor. Sequence-based classification of select agents. Washington, DC; 2010.
39.
go back to reference Atlas R, Campbell P, Cozzarelli NR, Curfman G, Enquist L, Fink G, et al. Statement on the consideration of biodefence and biosecurity. Nature. 2003;421:771.PubMedCrossRef Atlas R, Campbell P, Cozzarelli NR, Curfman G, Enquist L, Fink G, et al. Statement on the consideration of biodefence and biosecurity. Nature. 2003;421:771.PubMedCrossRef
40.
go back to reference Burns K, Casadevall A, Cohen M, Ehrlich S, Enquist L, Fitch J, et al. Adaptations of avian flu virus are a cause for concern. Science. 2012;335:660–1.CrossRef Burns K, Casadevall A, Cohen M, Ehrlich S, Enquist L, Fitch J, et al. Adaptations of avian flu virus are a cause for concern. Science. 2012;335:660–1.CrossRef
41.
go back to reference Hester S, Cacho O. The contribution of passive surveillance to invasive species management. Biol Invasions. 2017;19(737–48):737–48.CrossRef Hester S, Cacho O. The contribution of passive surveillance to invasive species management. Biol Invasions. 2017;19(737–48):737–48.CrossRef
42.
go back to reference Zuckerman M. Biosecurity: a 21st century challenge. New York City, NY: Carnegie Corporation of New York; 2005. Zuckerman M. Biosecurity: a 21st century challenge. New York City, NY: Carnegie Corporation of New York; 2005.
44.
go back to reference Du Toit A. Lassa fever outbreak in Nigeria. Nat Rev Microbiol. 2018;16:260.PubMed Du Toit A. Lassa fever outbreak in Nigeria. Nat Rev Microbiol. 2018;16:260.PubMed
45.
go back to reference Baker M, Forsyth A. The new international health regulations: a revolutionary change in global health security. N Z Med J. 2007;120:1267. Baker M, Forsyth A. The new international health regulations: a revolutionary change in global health security. N Z Med J. 2007;120:1267.
46.
go back to reference Murray K, Skerratt L, Speare R, et al. Cooling off health security hot spots: getting on top of it down under. Environ Int. 2012;48:56–64.PubMedCrossRef Murray K, Skerratt L, Speare R, et al. Cooling off health security hot spots: getting on top of it down under. Environ Int. 2012;48:56–64.PubMedCrossRef
47.
go back to reference Maye D, Dibden J, Higgins V, Potter C. Governing biosecurity in a neoliberal world: comparative perspectives from Australia and the United Kingdom. Environ Plan. 2012;44:150–68.CrossRef Maye D, Dibden J, Higgins V, Potter C. Governing biosecurity in a neoliberal world: comparative perspectives from Australia and the United Kingdom. Environ Plan. 2012;44:150–68.CrossRef
48.
49.
go back to reference Sun X, Keim M, Dong C, Mahany M, Guo X. A dynamic process of health risk assessment for business continuity management during the world exposition Shanghai, China, 2010. J Bus Contin Emer Plan. 2014;7(4):347–64.PubMed Sun X, Keim M, Dong C, Mahany M, Guo X. A dynamic process of health risk assessment for business continuity management during the world exposition Shanghai, China, 2010. J Bus Contin Emer Plan. 2014;7(4):347–64.PubMed
50.
go back to reference Koblentz G. From biodefence to biosecurity: the Obama administration’s strategy for countering biological threats. Int Aff. 2012;88(1):131–48.PubMedCrossRef Koblentz G. From biodefence to biosecurity: the Obama administration’s strategy for countering biological threats. Int Aff. 2012;88(1):131–48.PubMedCrossRef
51.
go back to reference Toner E, Waldhorn R, Franco C, Courtney B, Rambhia K, Norwood A, et al. Hospitals rising to the challenge: the first five years of the U.S. hospital preparedness program and priorities going forward. Washington, DC; 2009. Toner E, Waldhorn R, Franco C, Courtney B, Rambhia K, Norwood A, et al. Hospitals rising to the challenge: the first five years of the U.S. hospital preparedness program and priorities going forward. Washington, DC; 2009.
52.
go back to reference Katz R, Sorrell E, Kornbler S, Fischer J. Global Health security agenda and the international health regulations: moving forward. Biosecurity and Bioterrorism. Biodefense Strategy, Practice, and Science. 2014;12(5):231–8. Katz R, Sorrell E, Kornbler S, Fischer J. Global Health security agenda and the international health regulations: moving forward. Biosecurity and Bioterrorism. Biodefense Strategy, Practice, and Science. 2014;12(5):231–8.
53.
go back to reference Kamradt-Scott A. Securing indo-Pacific health security: Australia’s approach to regional health security. Aust J Int Aff. 2018;72(6):500–19.CrossRef Kamradt-Scott A. Securing indo-Pacific health security: Australia’s approach to regional health security. Aust J Int Aff. 2018;72(6):500–19.CrossRef
54.
go back to reference Bell E, Tappero J, Ijaz K, et al. Joint external evaluation—development and scale-up of global Multisectoral health capacity evaluation process. Emerg Infect Dis. 2017;23:S33–9.PubMedCentralCrossRef Bell E, Tappero J, Ijaz K, et al. Joint external evaluation—development and scale-up of global Multisectoral health capacity evaluation process. Emerg Infect Dis. 2017;23:S33–9.PubMedCentralCrossRef
55.
go back to reference Nixon S, Lee K, Bhutta Z, et al. Canada's global health role: supporting equity and global citizenship as a middle power. Lancet. 2018;391(10131):1736–48.PubMedCrossRef Nixon S, Lee K, Bhutta Z, et al. Canada's global health role: supporting equity and global citizenship as a middle power. Lancet. 2018;391(10131):1736–48.PubMedCrossRef
56.
go back to reference Nuzzo J, Inglesby TUS. Global Health security investments improve capacities for infectious disease emergencies. Health Security. 2018;16:S1.CrossRef Nuzzo J, Inglesby TUS. Global Health security investments improve capacities for infectious disease emergencies. Health Security. 2018;16:S1.CrossRef
57.
go back to reference U.S. Department of health and human services. Use, and Transfer of Select Agents and Toxins; Biennial Review; Final Rule. Washington, DC: Possession; 2012. U.S. Department of health and human services. Use, and Transfer of Select Agents and Toxins; Biennial Review; Final Rule. Washington, DC: Possession; 2012.
59.
go back to reference Rager-Zisman B. Ethical and regulatory challenges posed by synthetic biology. Perspect Biol Med. 2012;55(4):590–607.PubMedCrossRef Rager-Zisman B. Ethical and regulatory challenges posed by synthetic biology. Perspect Biol Med. 2012;55(4):590–607.PubMedCrossRef
60.
go back to reference Minarcine S. Health security intelligence: assessing the nascent public health capability. Monterey, CA: Department of National Security Affairs, Naval Postgraduate School; 2012. Minarcine S. Health security intelligence: assessing the nascent public health capability. Monterey, CA: Department of National Security Affairs, Naval Postgraduate School; 2012.
62.
go back to reference Canyon D, Burkle F, Speare R. Managing community resilience to climate extremes, rapid unsustainable urbanization, emergencies of scarcity, and biodiversity crises by use of a disaster risk reduction bank. Disaster Medicine and Public Health Preparedness. 2015;9(6):619–24.PubMedCrossRef Canyon D, Burkle F, Speare R. Managing community resilience to climate extremes, rapid unsustainable urbanization, emergencies of scarcity, and biodiversity crises by use of a disaster risk reduction bank. Disaster Medicine and Public Health Preparedness. 2015;9(6):619–24.PubMedCrossRef
63.
go back to reference Chrétien J. Adapting to health impacts of climate change in the Department of Defense. Health Security. 2016;14(2):86–92.PubMedCrossRef Chrétien J. Adapting to health impacts of climate change in the Department of Defense. Health Security. 2016;14(2):86–92.PubMedCrossRef
64.
go back to reference World Health Organization. In: Hales S, Kovats S, Lloyd S, Campbell-Lendrum D, editors. Quantitative risk assessment of the effects of climate change on selected causes of death, 2030s and 2050s. Geneva, Switzerland; 2014. World Health Organization. In: Hales S, Kovats S, Lloyd S, Campbell-Lendrum D, editors. Quantitative risk assessment of the effects of climate change on selected causes of death, 2030s and 2050s. Geneva, Switzerland; 2014.
65.
go back to reference Brioudes A, Gummow B. Field application of a combined pig and poultry market chain and risk pathway analysis within the Pacific Islands region as a tool for targeted disease surveillance and biosecurity. Prev Vet Med. 2016;129:13–22.PubMedCrossRef Brioudes A, Gummow B. Field application of a combined pig and poultry market chain and risk pathway analysis within the Pacific Islands region as a tool for targeted disease surveillance and biosecurity. Prev Vet Med. 2016;129:13–22.PubMedCrossRef
66.
go back to reference Graham J, Leibler J, Price L, Otte J, Pfeiffer D, Tiensin T, et al. The animal-human interface and infectious disease in industrial food animal production: rethinking biosecurity and biocontainment. Public Health Rep. 2008;123:282–99.PubMedPubMedCentralCrossRef Graham J, Leibler J, Price L, Otte J, Pfeiffer D, Tiensin T, et al. The animal-human interface and infectious disease in industrial food animal production: rethinking biosecurity and biocontainment. Public Health Rep. 2008;123:282–99.PubMedPubMedCentralCrossRef
67.
go back to reference Glassman A, Lofgren K. Getting serious on Global Health security. Global Health Policy Blog Washington, DC. 2016. Glassman A, Lofgren K. Getting serious on Global Health security. Global Health Policy Blog Washington, DC. 2016.
68.
go back to reference Clark M, Raffray M, Hendricks K, Gagnon A. Global and public health core competencies for nursing education: a systematic review of essential competencies. Nurse Educ Today. 2016;40:173–80.PubMedCrossRef Clark M, Raffray M, Hendricks K, Gagnon A. Global and public health core competencies for nursing education: a systematic review of essential competencies. Nurse Educ Today. 2016;40:173–80.PubMedCrossRef
69.
go back to reference Rhodes T. The ‘risk environment’: a framework for understanding and reducing drug-related harm. The. Int J Drug Policy. 2002;13(2):85–94.CrossRef Rhodes T. The ‘risk environment’: a framework for understanding and reducing drug-related harm. The. Int J Drug Policy. 2002;13(2):85–94.CrossRef
Metadata
Title
Establishing a theoretical foundation for measuring global health security: a scoping review
Authors
Sanjana J. Ravi
Diane Meyer
Elizabeth Cameron
Michelle Nalabandian
Beenish Pervaiz
Jennifer B. Nuzzo
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Public Health
Published in
BMC Public Health / Issue 1/2019
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-019-7216-0

Other articles of this Issue 1/2019

BMC Public Health 1/2019 Go to the issue